CMPI.org

In the News

Selective Transparency

05/18/2017 12:00 AM | The Institute for Policy Innovation

ICER Perpetuates the Opioid Crisis

05/11/2017 12:00 AM | Morning Consult

Peter Pitts discusses Scott Gottlieb and Healthcare Reform on the Bill Martinez Radio Show

05/09/2017 12:00 AM | Bill Martinez Radio Show

Blue Cross Blue Shield BS on Rx $

05/09/2017 12:00 AM | LinkedIn

Safety Events Common in Newly Approved Drugs

05/09/2017 12:00 AM | Medscape

Peter Pitts on Healthcare Bill's Passage in US House

05/04/2017 12:00 AM | i24NEWS

Peter Pitts discusses progress of GOP Healthcare Bill on i24NEWS

04/21/2017 12:00 AM | i24NEWS

Making Drug Manufacturing Great Again

04/21/2017 12:00 AM | Investor's Business Daily

Peter Pitts on Fox News: How the pharmaceutical industry fits into the opioid crisis

04/11/2017 12:00 AM | Fox News

Peter Pitts on WOR 710 "In The Arena"

04/11/2017 12:00 AM | WOR 710

How Trump and the FDA Can Create a Pharmaceutical Manufacturing Renaissance

04/10/2017 12:00 AM | Morning Consult

ICER Devalues People With Rheumatoid Arthritis

03/29/2017 12:00 AM | LinkedIn

Peter Pitts on CNBC: Revised 'bottom up' US healthcare bill delayed

03/23/2017 12:00 AM | CNBC

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

03/16/2017 12:00 AM | Medical Marketing & Media

CMPI President Peter J. Pitts discusses the American Health Care Act on i24News

03/14/2017 12:00 AM | i24NEWS

Peter Pitts discusses new GOP Healthcare Plan

03/09/2017 12:00 AM | i24NEWS

Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

03/08/2017 12:00 AM | NY1 News Capital Tonight

U.N.'s errant prescription for drug access

02/27/2017 12:00 AM | Pittsburgh Tribune

How Other Countries Freeload on U.S. Drug Research

02/21/2017 12:00 AM | Wall Street Journal

The Privacy Delusions Of Genetic Testing

02/15/2017 12:00 AM | Forbes

Previous
1
...
6
7
8
9
10
11
Next

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

STAT
03/03/2020 12:00 AM

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

STAT
10/17/2024 12:00 AM

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub... Read more

Tort bar’s newest collateral damage: Preterm babies

The Washington Times
07/02/2024 12:00 AM

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more

Read all News